DnB Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $281K | Buy |
163,505
+71,925
| +79% | +$124K | ﹤0.01% | 675 |
|
|
2025
Q1 | $305K | Buy |
91,580
+50,802
| +125% | +$169K | ﹤0.01% | 688 |
|
|
2024
Q4 | $302K | Buy |
40,778
+8,837
| +28% | +$65.4K | ﹤0.01% | 689 |
|
|
2024
Q3 | $300K | Buy |
31,941
+3,919
| +14% | +$36.8K | ﹤0.01% | 679 |
|
|
2024
Q2 | $224K | Buy |
28,022
+11,091
| +66% | +$88.8K | ﹤0.01% | 691 |
|
|
2024
Q1 | $251K | Buy |
+16,931
| New | +$251K | ﹤0.01% | 686 |
|